Lipodystrophy as a Late Effect after Stem Cell Transplantation

J Clin Med. 2021 Apr 8;10(8):1559. doi: 10.3390/jcm10081559.

Abstract

Survivors of childhood cancer are at high risk of developing metabolic diseases in adulthood. Recently, several patients developing partial lipodystrophy following hematopoietic stem cell transplantation (HSCT) have been described. In this review, we summarize the cases described so far and discuss potential underlying mechanisms of the disease. The findings suggest that HSCT-associated lipodystrophies may be seen as a novel form of acquired lipodystrophy.

Keywords: adipose tissue; lipodystrophy; stem cells.

Publication types

  • Review